US drugmaker Pfizer abandons plan to split into two companies; stock falls nearly 2%

US drugmaker Pfizer abandons plan to split into
Pfizer world headquarters in New York, United States. Image Source: Reuters

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x